Clinical Trials Directory

Trials / Completed

CompletedNCT01344265

The Correlation Between B-type Natriuretic Peptide (BNP) and Global End Diastolic Volume

The Correlation Between BNP and Global End Diastolic Volume

Status
Completed
Phase
Study type
Observational
Enrollment
46 (actual)
Sponsor
Jinhua Central Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The investigators hypothesized that the serum B-type Natriuretic Peptide (BNP) level may be correlated with global end diastolic volume (GEDV) as measured by transpulmonary thermodilution technique (PiCCO). The rationale is that some animal studies have proven that BNP is released from ventricular myocardium in response to physical expansion. Such physical expansion can be measured by GEDV. If the hypothesis can be confirmed with our study, the serum level BNP can be used to monitor volume status of critically ill patient, instead of the invasive monitoring system.

Conditions

Timeline

Start date
2010-06-01
Primary completion
2011-10-01
Completion
2011-10-01
First posted
2011-04-29
Last updated
2013-04-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01344265. Inclusion in this directory is not an endorsement.

The Correlation Between B-type Natriuretic Peptide (BNP) and Global End Diastolic Volume (NCT01344265) · Clinical Trials Directory